Robert Walley
Critical Care Medicine · Hattiesburg, MSNPI 1588047567
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 64.4% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $5,632, more than ten times the $421 reported in 2019. Among critical care medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $63.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- GSK$517
- AstraZeneca$252
- Viatris Specialty LLC$231
- Grifols USA, LLC$199
- Actelion Pharmaceuticals US, Inc.$185
- plus $1K from 20 others
What the payments were for
- Travel & lodging$92412%
- Food & beverage$2,71836%
- Education$4,00052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $4,924 |
| GSK | 26 | $517 |
| AstraZeneca(2 entities) | 12 | $252 |
| Viatris Specialty LLC | 18 | $231 |
| Grifols USA, LLC | 8 | $199 |
| Actelion Pharmaceuticals US, Inc. | 4 | $185 |
| Mylan Specialty L.p. | 9 | $172 |
| Abiomed | 4 | $159 |
| Genentech USA, Inc. | 1 | $122 |
| Insmed, Inc. | 2 | $122 |
| Pulmonx Corporation | 1 | $121 |
| United Therapeutics Corporation | 2 | $85 |
| Boehringer Ingelheim | 4 | $74 |
| AbbVie | 3 | $65 |
| Amgen | 2 | $58 |
| ANI Pharmaceuticals, Inc. | 3 | $53 |
| Sanofi | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Merck | 2 | $44 |
| Jazz Pharmaceuticals Inc. | 2 | $44 |
| Johnson & Johnson | 1 | $33 |
| Shionogi Inc | 1 | $21 |
| Baxter Healthcare | 1 | $19 |
| La Jolla Pharmaceutical Company | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,894
- UPTRAVI$125
- NUCALA$124
- CHARTIS CATHETER$121
- ZEPHYR DELIVERY CATHETER$121
- ZEPHYR ENDOBRONCHIAL VALVE$121
- PULMONX CHARTIS TABLET CONSOLE$121
- Arikayce$110
- Impella$103
How this compares
$7,643 in reported general payments places this provider in the 95th percentile of 23 critical care medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $41,673 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 40 | $18,726 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $4,678 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 76 | $2,206 |
| Ventolin HfaAlbuterol Sulfate | 12 | $652 |
| Fluticasone Propionate | 39 | $339 |
| Montelukast Sodium | 56 | $258 |
| Pantoprazole Sodium | 17 | $144 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $517 | $41,67361 claims |
| Boehringer IngelheimStiolto Respimat | $74 | $18,72640 claims |
| AstraZenecaSymbicort | $252 | $4,67821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 23 critical care medicine providers in Mississippi.
Other critical care medicine in Hattiesburg
- Joe PresslerHattiesburg$946
- Steven StognerHattiesburg$438
- Casie BarnesHattiesburg$95
- Eduardo SotoHattiesburg$88
- William AdcockHattiesburg$19
- Emily BrumfieldJackson$14K
- Todd HendersonSouthaven$5K
- Lekha DeereJackson$5K
- Geeta GyamlaniJackson$3K
- Lauren BeasleyColumbus$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.